New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 19, 2024 - Ionis Pharmaceuticals announced the FDA approval of Tryngolza (olezarsen), as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
Download PDF
Return to publications
